Marrone Bio Investors Say Ernst & Young Must Face Claims
By Kali Hays · August 2, 2016, 4:38 PM EDT
A class of Marrone Bio Innovations Inc. shareholders on Monday urged a California federal court not to dismiss claims against Ernst & Young LLP over its alleged role in the bio-based...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login